Skip to main content
SpringerLink
Log in

Oral clarithromycin cuts the cost of treating pneumonia

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Three recent studies have shown that cost savings can be made by using the antibacterial clarithromycin to treat hospitalised patients with community-acquired pneumonia. The findings of these studies were presented at the 3rd International Conference on the Macrolides, Azalides and Streptogramins [ Lisbon, Portugal; January 1996 ].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Jill Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stein, J. Oral clarithromycin cuts the cost of treating pneumonia. Inpharma Wkly. 1024, 7 (1996). https://doi.org/10.2165/00128413-199610240-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199610240-00013

Keywords

Search

Navigation